Carbiotix AB (publ) (NGM:CRBX)

Market Cap	32.74M -34.5%
Revenue (ttm)	2.31M -28.9%
Net Income	-14.46M
EPS	-3.10
Shares Out	4.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,438
Open	6.20
Previous Close	5.76
Day's Range	4.90 - 6.98
52-Week Range	3.70 - 14.75
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 13, 2026

About Carbiotix AB

Carbiotix AB (publ), a biotechnology company, develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops a prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides; and LinkGut, a health test. Carbiotix AB (publ) was incorporated in 2014 and is headquartered in Lund, Sweden.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2014
• Employees: 9
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CRBX

Financial Performance

In 2024, Carbiotix AB's revenue was 2.86 million, a decrease of -33.38% compared to the previous year's 4.29 million. Losses were -16.13 million, 19.7% more than in 2023.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Apr 3, 2026

Data Sources Report a data error